6-138430443-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001144060.2(NHSL1):c.3902C>T(p.Ala1301Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000137 in 1,537,180 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001144060.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NHSL1 | NM_001144060.2 | c.3902C>T | p.Ala1301Val | missense_variant | 6/8 | ENST00000343505.10 | NP_001137532.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NHSL1 | ENST00000343505.10 | c.3902C>T | p.Ala1301Val | missense_variant | 6/8 | 5 | NM_001144060.2 | ENSP00000344672.5 | ||
NHSL1 | ENST00000427025.6 | c.3914C>T | p.Ala1305Val | missense_variant | 5/7 | 5 | ENSP00000394546.2 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 152040Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000273 AC: 4AN: 146356Hom.: 0 AF XY: 0.0000260 AC XY: 2AN XY: 76982
GnomAD4 exome AF: 0.0000137 AC: 19AN: 1385140Hom.: 0 Cov.: 34 AF XY: 0.0000117 AC XY: 8AN XY: 681398
GnomAD4 genome AF: 0.0000132 AC: 2AN: 152040Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74260
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 20, 2023 | The c.3914C>T (p.A1305V) alteration is located in exon 5 (coding exon 5) of the NHSL1 gene. This alteration results from a C to T substitution at nucleotide position 3914, causing the alanine (A) at amino acid position 1305 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at